dafabet live casino

Owns 60 biopharmaceutical companies，28 of them are industrial enterprises above designated size，Two autonomous region chain master companies、7 leading technology companies;Has 143 innovative platform carriers、117 R&D institutions;602 registration approval documents for various types of drugs，1123 valid invention patents，Output value in 2023: 18.4 billion yuan，Accounting for about 7% of Hohhot City’s industrial industry... This is an eye-catching report card of Hohhot City’s efforts to create a new highland for the development of the biomedical industry，A set of data outlines the booming industrial development trajectory。

The biomedical industry is one of the “six major industrial clusters” that Hohhot City strives to cultivate。In recent years，Hohhot focuses on the theme of high-quality development in the field of biomedicine，Focus on technological empowerment、Innovative Development，Work together to promote the extension of the biomedical industry chain、Replenishing chain、Strong link，Strive to promote the high-quality development of biomedical industry clusters。

To provide strong support for the development of the biomedical industry，Published "Ten Measures for Hohhot to Support the High-Quality Development of the Biopharmaceutical Industry"，Extending development from supporting biological fermentation and pharmaceutical industries、Support the innovative development of the biological vaccine industry、Support the characteristic development of traditional dafabet online betting websiteChinese medicine (Mongolian medicine) industry、Support industrial scale and cluster development、Support five aspects of industrial factor-driven development to promote the integrated development of the entire industry chain，Significantly improve the comprehensive innovation capabilities of industrial clusters。

The Hohhot Economic and Technological Development Zone is the main battlefield of Hohhot’s industrial economy，Based on cultivating "six major industrial clusters"，Scientific planning of industrial layout，The biomedical industry has become the dominant industry in Hohhot Economic and Technological Development Zone。

“There are 21 biopharmaceutical companies in Hohhot Economic and Technological Development Zone，Accounting for one-third of the city’s biopharmaceutical companies，7 of them are enterprises above designated size，The city’s two major biopharmaceutical chain companies in the autonomous region are here，Two of the city’s four animal vaccine companies are also here。" said Anda, deputy secretary of the Party Working Committee of Hohhot Economic and Technological Development Zone。

It is reported，Hohhot Economic and Technological Development Zone will complete the total output value of biopharmaceutical and above-scale industries in 2023.800 million yuan，Accounting for 60% of the city’s total output value of biomedical industries above designated size，Including biological vaccine output value 9.9.3 billion yuan。January to July this year，Complete the total output value of biomedical industries above designated size 62.6.3 billion yuan，The output value of biological vaccines is nearly 400 million yuan，Biopharmaceutical industry cluster has outstanding characteristics。The biological vaccine industry is one of the three major areas of Hohhot’s biomedical industry cluster，Have both Jinyu creatures、Kanagawa Yumoto、Kanagawa Yumoto、The four major animal vaccine manufacturers of Huaxi Biotech，has become an important production base for animal vaccines in the country，We are building a first-class Dafabet reviewsbiological vaccine research and development base in China。

"Since the 13th Party Congress in Hohhot，We encourage technological innovation、Add advantageous products、Complete industry shortcomings、Optimizing industrial layout as the starting point，Support enterprises to build technological innovation platforms，Strengthen the technical research on "stuck neck"，Promote the industrialization of innovative products such as genetically engineered multi-linked vaccines，Strive to create new productivity。" Jia Jianyu, deputy director of the Municipal Science and Technology Bureau said。

According to introduction，Municipal Science and Technology Bureau is working on research and development、Continuous efforts in the construction of innovative platforms and other aspects，Support enterprises to take the lead in developing multi-linked and multivalent combination vaccines、"Revelation and leadership" of major technical breakthroughs in the fields of African swine fever vaccines，Constructing the Inner Mongolia Autonomous Region Animal Vaccine Technology Innovation Center，The research and development project of a high-efficiency vaccine for foot-and-mouth disease won the second prize of the National Science and Technology Progress Award，Built a first-class pig vaccine development and production base in the country。

Jinyu Biotechnology Co., Ltd. is the main enterprise in the biopharmaceutical industry chain of Inner Mongolia Autonomous Region and Hohhot City，The company actively participates in the construction of important ecological security barriers in the north and the construction of national agricultural and livestock product production bases，By establishing a big data platform for epidemic prevention and control，Implement active defense、Precise prevention and control，Effectively reduce the incidence of animal disease、Miscarriage and mortality rates，Improving the quality and efficiency of the breeding industry。In recent years，The company invests part of its sales dafabet live casinorevenue into technological innovation and research and development every year，The National Engineering Laboratory for Veterinary Vaccines and the Key Laboratory of Ruminant Biological Products of the Ministry of Agriculture and Rural Affairs have been established，has developed a number of important products that fill the gaps in domestic epidemic prevention。

"Next step，We will give full play to the advantages of the animal vaccine industry，Further improve the construction of animal vaccine industry innovation system，Promote the upgrading of production bases，Support animal vaccine companies to become bigger and stronger，Continue to improve the development level of the animal vaccine industry，Build a solid national animal biosafety risk prevention and control barrier，Make greater contributions to the sustainable and healthy development of animal husbandry。" said Mei Hua, deputy director of the Municipal Agriculture and Animal Husbandry Bureau。

Source: Hohhot Daily